Kanger International Berhad Balance Sheet Health

Financial Health criteria checks 6/6

Kanger International Berhad has a total shareholder equity of MYR293.8M and total debt of MYR0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are MYR327.1M and MYR33.3M respectively. Kanger International Berhad's EBIT is MYR8.3M making its interest coverage ratio 14.8. It has cash and short-term investments of MYR482.0K.

Key information

Debt to equity ratio

RM0

Debt

Interest coverage ratio	14.8x
Cash	RM482.00k
Equity	RM293.76m
Total liabilities	RM33.30m
Total assets	RM327.06m

Recent financial health updates

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Aug 30

Kanger International Berhad (KLSE:KANGER) Has Debt But No Earnings; Should You Worry?

May 17

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Nov 23

Recent updates

We Think That There Are Some Issues For Kanger International Berhad (KLSE:KANGER) Beyond Its Promising Earnings

Feb 09

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Aug 30

Kanger International Berhad (KLSE:KANGER) Has Debt But No Earnings; Should You Worry?

May 17

Kanger International Berhad's (KLSE:KANGER) Stock Price Has Reduced 21% In The Past Five Years

Mar 08

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Nov 23

Financial Position Analysis

Short Term Liabilities: KANGER's short term assets (MYR117.9M) exceed its short term liabilities (MYR32.4M).

Long Term Liabilities: KANGER's short term assets (MYR117.9M) exceed its long term liabilities (MYR855.0K).

Debt to Equity History and Analysis

Debt Level: KANGER is debt free.

Reducing Debt: KANGER has no debt compared to 5 years ago when its debt to equity ratio was 48.4%.

Debt Coverage: KANGER has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: KANGER has no debt, therefore coverage of interest payments is not a concern.

Kanger International Berhad Balance Sheet Health

Financial Health criteria checks 6/6

Key information

Recent financial health updates

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Kanger International Berhad (KLSE:KANGER) Has Debt But No Earnings; Should You Worry?

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Recent updates

First quarter 2024 earnings released: RM0.001 loss per share (vs RM0.004 loss in 1Q 2023)

We Think That There Are Some Issues For Kanger International Berhad (KLSE:KANGER) Beyond Its Promising Earnings

Kanger International Berhad, Annual General Meeting, Mar 26, 2024

Kanger International Berhad Appoints Chong Kwang Fock as Independent and Non Executive Director

Kanger International Berhad Announces Resignation of Kuah Choon Ching as Executive Director

Second quarter 2024 earnings released: EPS: RM0.006 (vs RM0.022 loss in 2Q 2023)

Kanger International Berhad Appoints Jeremy Tai Yung Wei as Company Secretary

Kanger International Berhad (KLSE:KANGER) agreed to acquire remaining 49% stake in Sung Master Holdings Sdn. Bhd. from Wong Seen for MYR72 million.

New major risk - Market cap size

First quarter 2024 earnings released: RM0.002 loss per share (vs RM0.005 loss in 1Q 2023)

High number of new and inexperienced directors

Kanger International Berhad Appoints Madam Lean Boon Bee as Independent and Non Executive Director

Full year 2023 earnings released: RM0.031 loss per share (vs RM0.34 loss in FY 2022)

Third quarter 2023 earnings released: RM0.004 loss per share (vs RM0.17 loss in 3Q 2022)

Second quarter 2023 earnings released: RM0.022 loss per share (vs RM0.11 loss in 2Q 2022)

High number of new and inexperienced directors

Zeng RongYing entered into a share purchase agreement to acquire Kanger Trading (HK) Co.Ltd from Kanger International Berhad (KLSE:KANGER) for RYM 4.6265 on September 29, 2022.

Zeng RongYing entered into a share purchase agreement to acquire Kanger Trading (HK) Co.Ltd from Kanger International Berhad (KLSE:KANGER) for RYM 4.6265 on September 29, 2022.

Kanger International Berhad, Annual General Meeting, Aug 29, 2022

Kanger International Berhad Reports Impairment Charges for the Quarter Ended March 31, 2022

Kanger International Berhad Announces Resignation of Wong Yuet Chyn as Company Secretary

High number of new and inexperienced directors

High number of new and inexperienced directors

Kanger International Berhad Announces Appointment of Azmil Bin Mohd Zabidi as Independent and Non Executive Member of Risk Committee

Chief Financial Officer Xiuxia Zhan has left the company

Kanger International Berhad (KLSE:KANGER) completed the acquisition of 51% stake in Sung Master Holdings Sdn. Bdn for MYR 94.8 million.

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

First quarter 2021 earnings released: RM0.01 loss per share (vs RM0.003 loss in 1Q 2020)

Kanger International Berhad (KLSE:KANGER) Has Debt But No Earnings; Should You Worry?

Full year 2020 earnings released: RM0.021 loss per share (vs RM0.007 profit in FY 2019)

Kanger International Berhad's (KLSE:KANGER) Stock Price Has Reduced 21% In The Past Five Years

Kanger International Berhad Announces Appointment of Mazlan Bin Mohamad as Independent and Non Executive Director

Kanger International Berhad Announces Resignation of Md Zabid Bin Haji Abdul Rashid as Chairman of Audit Committee, Date of Change 31 Dec 2020

Third quarter 2020 earnings released: RM0.003 loss per share

Is Kanger International Berhad (KLSE:KANGER) A Risky Investment?

Kanger International Berhad Announces Appointment of DATUK NUR JAZLAN BIN MOHAMED as Independent and Non Executive Member of Audit Committee

Kanger International Berhad and Sinopharm Group Hunan Changde Medical Co. Ltd Enters into a Collaboration Agreement

Kanger International Berhad Appoints LOW POH SEONG as Independent and Non Executive Director

Kanger International Berhad Announces Resignation of Dato' Paduka Sharipah Hishmah Binti Dato' Sayed Hassan as Non Independent and Non Executive Chairman

New 90-day high - RM0.30

First half earnings released

New 90-day high - RM0.23

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies